-
TREATMENT AFTER CAR T-CELL THERAPY FAILURE IN DIFFUSE LARGE B-CELL LYMPHOMA: HEMATOLOGIST/ONCOLOGISTS’ PERSPECTIVES ON ODRONEXTAMAB AND RESULTS FROM THE ELM-1 STUDY
Mar 18, 2026, 21:38 PM -
ASSESSING THE PSYCHOMETRIC PROPERTIES OF TWO INSTRUMENTS MEASURING ATTITUDES TOWARDS AI AND THEIR ASSOCIATED FACTORS
Mar 18, 2026, 21:38 PM -
ACCESS TO INNOVATIVE AUTOIMMUNE THERAPIES IN LATIN AMERICA: CROSS-COUNTRY EVIDENCE TO INFORM VALUE-BASED DECISION-MAKING
Mar 18, 2026, 21:38 PM -
THE TOTAL COST OF CARE AND BUDGET IMPACT OF INTRODUCING MOSUNETUZUMAB PLUS POLATUZUMAB VEDOTIN FOR SECOND-LINE OR LATER (2L+) TREATMENT OF RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (LBCL) TO A UNITED STATES (US) HEALTH PLAN
Mar 18, 2026, 21:38 PM -
HOW INDIVIDUALS CHOOSE MEDICATIONS: A DISCRETE CHOICE EXPERIMENT TO UNDERSTAND MANAGEMENT OF EYE ALLERGY RX TO OTC TREATMENT DECISIONS
Mar 18, 2026, 21:38 PM -
STATIN INITIATION TIME AFTER GRAVES' DISEASE DIAGNOSIS AND THE RISK OF GRAVES' ORBITOPATHY: A ONE-YEAR LANDMARK ANALYSIS
Mar 18, 2026, 21:38 PM -
MACHINE LEARNING MODELS FOR PREDICTING SERIOUS ADVERSE EVENT REPORTS IN GLP-1 RECEPTOR AGONISTS USING FAERS, 2015-2025
Mar 18, 2026, 21:38 PM -
HOSPITAL LENGTH OF STAY AMONG MEDICARE BENEFICIARIES UNDERGOING TRANSCAROTID ARTERY REVASCULARIZATION VERSUS CAROTID ENDARTERECTOMY: A RETROSPECTIVE CLAIMS ANALYSIS
Mar 18, 2026, 21:38 PM -
ELEVATE GEN-AI FRAMEWORK-BASED INTERIM EVALUATION OF A GENAI-ENABLED PLATFORM FOR LITERATURE SCREENING OF A CLASS II MEDICAL DEVICE
Mar 18, 2026, 21:38 PM -
REAL-WORLD SAFETY OF XANOMELINE/TROSPIUM CHLORIDE IN SCHIZOPHRENIA MANAGEMENT
Mar 18, 2026, 21:38 PM -
MEASURING VALUE IN SURGERY: A SYSTEMATIC REVIEW OF ECONOMIC INDICES ACROSS SPECIALTIES
Mar 18, 2026, 21:38 PM -
BLINATUMOMAB FOR FIRST RELAPSE OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A SINGLE-CENTER AMBISPECTIVE COHORT STUDY FROM CARTAGENA, COLOMBIA
Mar 18, 2026, 21:38 PM -
COMPARING AN EXPERT-IN-THE-LOOP AI WORKFLOW WITH MANUAL SYSTEMATIC LITERATURE REVIEW: IMPLICATIONS FOR EFFICIENCY AND EVIDENCE QUALITY IN HEOR
Mar 18, 2026, 21:38 PM -
REAL-WORLD CTDNA TEST UTILIZATION AND ASSOCIATED COSTS IN US PATIENTS WITH BLADDER CANCER WHO UNDERWENT RADICAL CYSTECTOMY
Mar 18, 2026, 21:38 PM -
MULTIMORBIDITY PATTERNS AMONG FUNCTIONALLY DEPENDENT ELDERLY ADULTS IN THE UNITED STATES: A LATENT CLASS ANALYSIS
Mar 18, 2026, 21:38 PM -
REAL-WORLD RELIABILITY AND VALIDITY OF THE EQ-5D-5L IN CHINESE PATIENTS WITH DIABETIC KIDNEY DISEASE: A CROSS-SECTIONAL STUDY
Mar 18, 2026, 21:38 PM -
EXPLORING THE RELATIONSHIP BETWEEN HEALTH-RELATED SOCIAL NEEDS AND CHRONIC DISEASE AMONG JEFFERSON HEALTH PATIENTS
Mar 18, 2026, 21:38 PM -
THE ECONOMIC IMPACT OF METABOLIC SYNDROME IN SCHIZOPHRENIA: A CLAIMS-BASED ANALYSIS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
PHYSICAL ACTIVITY AND OUT OF POCKET HEALTH CARE EXPENDITURES AMONG BREAST CANCER SURVIVORS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
EVALUATING PER-MEMBER-PER-MONTH EXPENDITURE BENCHMARKS IN NON-ONCOLOGY: TARGETED REVIEW IN CANADA
Mar 18, 2026, 21:38 PM
